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DNA-damaging agents are widely u sed as therapeutic 
tools for a variety of disease states. Many such agents 
are considered to produce detrimental s ide effects. Thus, 
it is important to evaluate both therapeutic efficacy and 
potential risk. DNA-damaging agents can b e s o e valu-
ated by comparison to agents whose therapeutic b e n e fit 
and potential hazards are bette r known. W e propose a 
framework for such comparison, demonstrating that a 
simple transformation of cytotoxicity-dose response pat-
terns permits a facile comparison of variation between 
cells exposed to a single DNA-damaging agent or to 
different cytotoxic agents. Further, by transforming data 
from experiments which compare res ponses of 2 cell 
populations to an effects ratio, different patterns for the 
changes in cytotoxicity produced by e pige n e tic and ge-
netic factors were compared. Using these transforma-
t ions, we found that there is a wide variation (a factor of 
4) between laboratories for a s ingle agent (UVC) and 
only a slightly larger variation (factor of 6) between 
normal cell response for different types of DNA-damag-
ing agents (x-ray, UVC, alkylating agents, crosslinking 
agents). Epigenetic factors s u ch as repair and recovery 
appear to be a factor only at higher dose levels . Compar-
ison in the cytotoxic effect of a spectrum of DNA-dam-
aging agents in xerod e rma pigme ntos um, ataxia telan-
giectasia, and Fanconi's anemia cells indicates signifi-
cantly different patterns, implying that the effect, and 
perhaps the nature , of these g e netic conditions are quite 
different. 
Both genetic and epigenetic factors can al ter rather dramat-
ically the cytotoxic response of huma n cells to DNA da maging 
agents. This paper will examine the degree a nd nature of 
alterations in t he cytotoxic response of huma n cells to selected 
agen ts. Specifically, we will examine the cha nges which are 
induced by several genetic a nd epigenetic factors as a function 
of dose a nd as a fun ct ion of chemical nature for a variety of 
DNA-damaging agents . The purpose of t his examination will 
be to seek statem ents as to the general nature of the response 
of huma n cells to DNA-damaging agents for a single quantita-
tive endpoint, cytotoxicity , selected because of t he large quan-
t ity of data available a nd because of the mathem atical proper-
t ies of that endpoin t. These statem ents can be used as a 
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fra m ework to evaluate on a comparative basis the natUJ'e of 
several DNA-damaging agents. 
Patterns of cytotoxicity in cul tured m a mmalia n cells as m ea-
sm ed by colony forma t ion techniques produce discrete quanti-
tative data, a nd offer the opportu ni ty to a pply rather sophisti-
cated mathem a tic a nalyses in t he attempt to correlate t he 
empirical observation with some causal molecular event, The 
classic work in t his area was proba bly that of Lea in his 
m onograph , Actions of Radiations on Living Cells [1). The 
continuing failure, subsequent to such work, to identify discrete 
molecular events which could be iden t ified as t he causal even t, 
has produced waning interest in th e so called "hi t-target" 
t heory. N ever theless, t he concep tual approach to this t heory is 
useful a nd permits comparison of different " lethal" agents 
through definition of t he "mean leth al hi t" (MLH), that is, t he 
dose which reduces survival by .37 on the port ion where killing 
is exponentia l. T his is not only a convenient transformation, 
but also seems theoretically sound in t hat it is the normalization 
of cytotoxic data by a characteristic of th e cytotoxicity itself, 
specifically, t he m aximum rate of induced cytotoxicity. 
MA TERIALS AND METHODS 
T he reduction of data to standardized dose from uni ts of dose fo r 
individual damaging agents is accomplished by first estimating the 
MLH. This is defin ed as the dose required to reduce a surviving fraction 
on the exponential part of the curve to .37 of that surviva l. When this 
number is obtained, the abscissa is now transformed into these units. 
Figure 1 illustrates this transformation for 2 diverse agents: et hylme-
thane sul fo nate (EMS) and pretreatment with 8- methoxypsoralen fo l-
lowed by graded dose of ultraviolet A light (PUVA). Both of these data 
curves were taken from reference 2. When red uced by the MLH 
transformation, the shape of the curves are qui te imi.lar. Note that the 
characteristic of this transformation is to force cell survival data to 
have a slope of 1 MLH per .37 reduction in surviva l. In uti lizing data 
from the li terature, the CUJ've wh ich the authors drew from the data is 
used, not the individual data points. 
The other transformation of data used is the calculation of an effects 
ratio between 2 cell st.rains or lines which have either different genetic 
makeups, or between the same cell line/stra in experiencing different 
epigenetic manipulations. An example of thi transformation is shown 
in Fig 2. These data by M.A. Ritter and J .R. Will iams, unpublished, 
are a compw'ison of survival of normal human diploid skin fibroblasts, 
Li 106, and diploid skin fibroblasts derived from a patient with xero-
derma pigmentosum (group A) , CRL 23, when treated with flu orescent 
light. Panel 2a shows the 2 survival curves in uni ts of flu orescent light 
exposure; panel 2b in uni ts of MLH. On pall el 2b and 2c the bWTed 
lines indicate the essence of the transformation to a new parameter, ~, 
which we call the effects ratio, defined as the ratio between survival of 
the non normal cells or manipulated cells to that of normal cells, treated 
under standard conditions. As the barred lines indicate, the transfor-
mation in effect flattens the normal curve along ~ = I , and reduces the 
2 curves to a single curve which is the pattern of vW'iation in the 
differential effect as a function of MLH. 
T his transformation permi ts a better analytical approach to describ-
ing the difference between the 2 curves in panel 2a, by reducing the 2 
curves to a single cUJ've, wh ich we find by experience is often a straight 
line or a combination of linear components. If the curve of ~ = 1, MLH 
= 0, then the condi tion producing the difference between the two 
curves c<ln· be defined as an "effect- modify ing-factor" (EMF) . An EMF 
indicates that the condi tion producing the diffe rence between the 2 
curves has the property of magnifying or diminishing the response 
proportionally at every dose. The data in Fig 2c indicate tha t the 
genetic defect in XP ce Ll strain CRL 1223 (XP12BE) acts consistently 
with an EMF. This in turn would indicate that, at least fo r the single 
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FIG I . S urviva l da ta normalized to maximum ra te of cytotoxicity. 
Panel 0: Hu man dip loid fib rob lasts (N HSF6) trea t.ed with eithe r 
ethyl methane sulfona te or pretreatment with 8-methoxypsora len fol-
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endpoin t of cy totoxicity, a ll ranges of exposure to flu orescent ligh t 
would be more effective in XP cells in increasing cell killing and, th us, 
t here appeaJ·s to be no "threshold" fo r poss ible deleterious effec t. If 
the re is a t h reshold, then t here mus t be 2 infl ec t ions of t he e ffects curve 
a t doses lower than t he last data poin t. 
RESULTS 
Variation between Norm al Cells for a Sing le Agent 
To approximate the variation of huma n diploid fibroblasts in 
cytotoxic response under normal condit ions for a single agent, 
survival curves after ult raviolet C light (UVC) , 254 nm, hom 
several laboratories wer e compa red . These a re shown in F ig 3. 
T he variation was greater than was expected wi th a di fference 
by a factor of almost 4 at higher MLH values. Possible expla -
nations woul d center on cul ture condit ions or on the presence 
of sensit ive subpopulations in the exposed cells, or perhaps 
sma ll intrinsic genetic differences . W hatever the cause, t his 
variation must be accepted as the li mit on in terpretation of 
small va riations in cytotoxic response . 
Variation between T oxic Agen ts in Normal Cells 
T he variation is not much greater in cytotox ic response when 
normal diploid cells are exposed to several agents known to 
induce D NA lesions of greatly differ ent character. The data in 
Fig 4 show the normalized cytotox ic response when normal 
fib roblasts are treated wi th methylmethane sulfonate (2) , Bu-
sul fa n (2), ni t rogen mustard (2), act inomycin D (8), the 5,6 
oxide of d imethyl benzanthracene (9), ult raviolet light C (6) and 
x-rays (7) . 
The ra nge of responses is only increased by a fac tor of 
lowed by UVA ligh t (ref 2). MLH is dete rmined by the dose necessary 
to reduce t he surv iving fraction by .37 on t he exponentia l part of t he 
curve. Panel b: data from panel a is no rma lized to dose uni ts of MLH. 
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F IG 3. Comparison of UVC surviva l curves norma lized to MLH of 
severa l norma l d iploid huma n skin fibroblasts. A, IBR, 4BR, IB1 a nd 
2B I (ref. 3 ); B, NHSF3 (re f. 4); C, unide nt ified norma l (ref. 5); D, 
unidentified normal (ref. 6); E, NHSF6 (ref. 2). 
approximately .5 (from 4 to abo ut 6). A new shape to the 
survival cUJ've is seen in this figure. DMBA (5,6 ox) and Act D 
are characteristic of a class of compounds which are considered 
to have "no shoulder" on the survival curve, that is, the surviva l 
curve appears lineal' through the point (surviving fraction = 
1.0, dose = 0). Although some investigators have described such 
a sUJ'vivai shape as indicating the induction oflesions which are 
refractory to t he cells' repair system, there is little direct 
evidence for such a theory. Nevertheless, the absence of an 
apparent tlU'eshold would suggest that even qui te low doses of 
such a n agent are cytotoxic. 
Changes in Cytotoxic Patterns Due to Epigenetic Factors 
The limited variation in Fig 4 could be interpreted as al'guing 
that normal cells have a nalTOW range of in trinsic response to 
DNA-damaging agents. An approach to this question is to 
describe 3 epigenetic condi tio ns in which treated cells wi th a 
common genetic condition express different cytotoxic respo nses. 
Diploid cells are not as well suited to repeated protracted 
experimentation as established cell lines, therefore epigenetic 
variation wiII be described in a cloned, aneuploid cell line. T his 
FIG 2. Compara tive surviva l data between normal hu man skin fi-
broblasts (Li 106) and fibroblasts from a xeroderma pigmentosum 
patient (CRL 1223, a lso denoted XP12BE) exposed to graded doses of 
fluorescent light. Panel a : surviva l as a function of exposed dose (Ritter 
and Willia ms, unpublished data). Panel Ii : da ta in pa nel a norma lized 
to MLH of normal cells. Panel c : effects ratio dete rmined from pan el 
b. Bars in panels Ii a nd c r epresent the ratio between surviva l levels of 
muta n t to normal ce lls. 0 is the slope of the effects curve, expressed as 
t he mean letha l hi ts necessar y to reduce surviva l to 37% 
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FIG 4. Comparison of normalized survi val curves of normal human 
diploid fibroblasts exposed to several DNA-damaging agents. BS, bu-
sulfan, NHSF6 cells (ref. 2); H N2, ni trogen mustard, NHSF6 cells (ref. 
2); x ·ray, x-irradiation, Li 106 cells (ref. 7); MMS, methylmethane 
sulfonate, NHSF6 (ref. 2) ; ACT D, actinomycin D, average of 6 normal 
human strains (re f. 8); DMBA (5,(J ox), 5,6 oxide of 7,12-dimethyl-
benz(a)anthracene, unidentified normal human strain (ref. 9); UVC, 
UV light at 254 11m, unidentified normal human strain (ref. 6). Stippled 
a/'ea represents range of survival of normal diploid human fibroblasts 
to UVC from Fig 3. 
line, designated U CH-O, although reported init ially to be de-
ri ved from normal human liver cells [10], may in reality be 
HeLa cells. In any case th ese cells have been extensively studied 
in several laboratories. Their response to radiations and chem-
icals seems within the range of resp.onse of normal diploid 
fibroblasts. The response to UVC for UCH-O cells is shown in 
Fig 5. A demonstration of an epigenetic variation in cytotoxic 
response is illustrated at high doses by the second component 
or " resistan t-tail" to the survival curve. This component of 
resistan t ceUs has been studied by one of us (JRW, reference 
11), and has been shown not to be a unique su bpopuJation, but 
to be a manifested state of the same population as the more 
sensitive cells; they are predominantly cells in the G2-mitotic 
phases of the cell cycle. The exact nature of the resistance of 
these cells is unknown. Lytle [12] in evaluating the survival of 
irradiated DNA virus plated on cell populations, however , 
observed a similar 2 component cw've,' and concluded that a 
minor portion of the cells had an increased DNA repair capac-
·ity. Whatever the cause, it is clear that gentically identical cells 
can exhibit a cytotoxic response to a DNA-damaging agent 
resistant by an EMF of 2.8 or greater. It is not known whether 
cells in vivo can exhibit such a response. 
Two further factors can be cons idered to be epigenetic vari-
ation in response. These factors are termed recovery processes: 
"split dose" recovery (SDR) and "potent ially-lethal-damage" 
recovery (PLD). SDR is associated with the rate at which the 
damaging agent is administered. Although this recovery phe-
nomenon is thought to be directly rela ted only to agents which 
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FIG 5. Survival of LICH-O (HeLa) cells exposed to UVC. Stippled 
area represents range of response of normal human diploid fibroblasts 
to UVC fro m Fig 3. The dose needed to reduce survival of the resistant 
population by .37 is 2.8 MLH units (Ritter and Williams, unpublished 
data). 
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FIG 6. Effects ratio as a funct ion of MLH between LICH-O (HeLa) 
cells given a dose of x· irradiation as indicated with the residual dose 
given 4 hI' later and similar cells given the entire dose acutely. Data of 
J .R. Williams and J.B. Little, unpublished data. 
exhibit the shouldered sUl'vival curve, this may not be en tire ly 
true. These 2 phenomena are discussed in detail in r eference 
13, and will be presented h ere in the form of the effects ratio 
between cells undergoing these recovery phenomena and cells 
treated in a manner which does not permit such r ecovery. The 
pattern for SDR is shown in Fig 6. In an experiment of this 
J uly 1981 
type, an initial dose is given to the cells and after an appropriate 
recovery interval the residual dose is given. In Fig 6 three 
experiments ar e illustrated , each differen t only by the size of 
t h e initial dose (100, 200, or 400 rads). All recovering cells were 
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FIG 7. Effects ratio as a function of' MLH of plateau cul tures of 
L ICH-O (HeLa) permi tted to remain in stationary phase for 4 hI' 
subsequent to x-irradiation and similar cul tures subcul tured immedi-
ately. Data of J .R Wil liams and J .B. Little, unpublished data. 
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FIG 8. Survival data normalized to maximum raLe of cytotoxicity in 
LICH-O (HeLa) ceUs of 2 selected, UV- resistant cell lines, LICH-M 4 
and LICH-UX-2. Data from J.R. Williams and J .B. Little, unpublished 
data. 
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permitted a 4-hr repair interval before receiving the residual 
dose to ma ke up th e total dose sh own on the absicssa in uni ts 
of MLH. T hese " recovered" cells are compared through the 
effects ratio to cells receiving t heir total dose in a single acute 
exposure. It is clear that SDR is dose-dependent, and one would 
expect at very low init ial doses that the cytotoxic effect would 
be negligible. Although SDR is important at therapeut ic levels, 
it may be unimportant at backgr ound and quasi-background 
levels . 
The effects ratio for PLD recovery is shown in Fig 7. PLD 
recovery is an enhanced survival observed in cells permitted to 
remain in suboptimal growth co ndi t ions during a recovery 
interval. In Fig 7 the effects rat io has been calculated as a 
function of dose in MLH between density inhibited cells per-
mitted to remain in that state for 4 hI' after x-in-adiation or 
subcul tured im mediately, which prevents PLD recovery. The 
extrapolation of the log g vs. MLH curve through g = 1, clearly 
does not pass through MLH = 0, indicating that PLD recovery 
as a n epigenetic factor does not playa major role at low doses, 
but again may be quantatively important only at high er doses. 
Genetic Factors 
Genetic factors can alter cytotoxic response to DNA-damag-
ing agents to a greater extent than epigenetic factors. Again , to 
illustrate one facet of epigenetic variation, experiments with 
LICH-O (HeLa) are useful , since mutant sublines have been 
isolated in culture which evidence genetic changes enhancing 
survival. Figure 8 illustrates this point. 
LICH-M4 was isolated as described in the li terature [14]. 
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FI G 9. Effects ratio between normal diploid human skin fib roblasts 
and various xeroderma pigmentosum complementation groups after 
UVC exposure. Group D, average effects ratio of XP5BE, XP6BE, 
XP7BE, XPKABE, XP2NE and XP3NE (ref. 17) ; group A, XP1 2BE 
(ref. 5); group C, XP2BE (ref'. 5); variants, average effects ratio of 
XP4BE and XP I3BE (ref. 18). The dose necessary to reduce the effects 
ratio by .37 is indicated as O. 
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FIG 10. Effects ratio as a function of MLH of normal human diploid 
fibroblasts for fib roblasts from XP patients treated with various DNA-
damaging agents: N-Aco-AAP, N-acetoxy-4-acetyl-aminobiphenyl, 
XP l2BE (ref. 19); 7-BrMBA, 7-Bromomethylbenz(a)anthracene, 
XP 12BE (ref. 20)"; DMMC, decru·bamoyl mitomycin C, XP20S (ref. 4) ; 
FL, fl uorescent light, XPI2BE, data from Fig 2c; Cis Pt (iI) , Cis-
platinum(Il)diammine dichloride, XP I2BE (re f. 21); MM C, mitomycin 
C, XP20S, XP4 KO (ref. 4). The dose necessary to reduce the effects 
ratio by .37 is indicated as 0 for each agent. 
LICH -1)X2 was isolated serendipi tously (JR Williams and JB 
Li ttle, unpu blished data). Both sublines have a n enhanced 
thJ-esh old for th e toxic effects of UVC. wi th the MLH being 
quite simila r . Both sublines respond to x-irradiation identically 
to th e paren t Ijne. T he nature of the U VC resistance is un-
known, bu t is an herita ble alteration. The best examples of 
genetic factors in cytotoxicity, and pJ'oba bly the most important 
in a pplying such knowledge to huma n beings, a re those ident i-
fied by isolating cells from patien ts with genetic disease. The 
pioneering work by Cleaver and his co-workers in chal'acterizing 
survival and D NA repa ir defi ciency in cells from patien ts wi th 
xeroderma pigmentosum [15,16] was the stimulus for similar 
studies in a variety of human condi t ions, studies vaJ-ying in 
degree of success. As will be discussed subsequently, the at-
. tem pts to establish exact para ll els between defects in XP and 
other genetic condit ions is perhaps un~arranted . The subse-
quent data analysis will be selective rather than com prehensive. 
Only data where cytotoxic response was compared dU'ectly 
between cells from genetic syndromes and cells from skin 
biopsies of individua ls considered to be normal wiU be included. 
It is interesting from OUJ' own studies that ~ varies less between 
experiments than do th e a bsolu te survival levels. 
It is clear that cells from different individua ls pur ported to 
have the same genetic condi t ion exhibi t di fferent characteristics 
of survival a nd D N A repair. Again , the clearest and most 
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extensive data is for XP, a nd that condit ion is discussed more 
extensively by others at this conference. H owever , for an ex-
ample of t he range of response of XP cells, we have selected 
some of the more extensive survival data to conver t to patterns 
of the effects ratio. These are shown in Fig 9 where various cell 
XP lines in several complem entation groups aTe analyzed b y 
th e effects ratio for UVC cytotoxicity. 
The importan t ch aTacteristics of these patterns are in th e 
wide range of response a nd the fact that th e log effects ratio vs . 
MLH curves a re consisten t with extra polation thJ"Ough th e 
poin t ~ = 1.0, MLH = O. This in turn indicates that the XP 
genetic defects appear to be effect-modifying over all dose 
ranges, implying that environmental doses would be effective 
in producing detriment in th e XP patien t. This is certainly 
borne out by the clinical character of this sync!J·om e. 
A potent ia lly powerful use of a bat tery of mutant cell lines, 
each wi th a presumed single defect in response, is the devel-
opment of descrip tors for a particula r chemical agent. The 
na ture of t he molecular -biological dam age induced by a chem-
ical agen t is a most importa nt consideration of its poten t ial 
harm to huma n beings. Thus, comparing the effectiveness of a 
chemical in t he induction of cytotoxicity in a group of peculiar 
cell lines would be a facile way to compare its biological activity 
to other chemicals which are better known. Figure 10 illustrates 
the use of ~ for such a descript ion . 
The data fo r this figure al'e derived fr om sUl"vival studies 
wi th 2 XP complementation group A cells: XP12BE a nd 
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FIG 11. Effect ratio as a function of MLH of normal diploid fi bro-
blasts fo r fibroblasts from AT patients treated with various DNA-
damaging agents. x- ray, x- irradiation, CRL-1343 (ref. 7); MNNG, N-
methyl-N' ·nitro-N-nitrosoguanidine, average effects ratio of CHL J 312, 
AT3BI , CRL 1343, AT5B1, CRL1347 and AT81CTO (ref. 22); BLEO, 
bleomycin , average effects ratio of AT4BI and AT7Bl (ref. 23); ACT 
D, actinomycin D, AT (unidentified) (ref. 8); M M C, mitomycin C, AT95 
(ref. 8). The dose necessru'y to reduce the effects ratio by .37 is indicated 
as 0 for each agent. 
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XP20S. These 2 cell populations respond quite similarly to 
UVC (8 for XP12BE = .09; 8 for XP20S = .08). In Fig 10 the 
patterns for response to mitomycin C, cis-plat inum-
(II)diammine dichloride, fluorescent light, decarba moyl mito-
mycin C, 7 -bromomethylbenz(a) anthracene, and N -acetoxy-4-
acetylaminobiphenyl ar e described as log ~ vs. MLH. As an 
example of the usefulness of such descriptors, it is straightfor-
ward from such a display to express a concern, for instance, 
t hat unshielded fluorescent ligh t should be considered a genet-
ically toxic agent. 
Other genetic syndromes are presently being studied in a 
m anner which parallels prev ious studies in XP, the most com-
mon being ataxia telangiectasia (AT) and Fanconi 's anemia 
(FA). Survival studies from the li terature for these 2 syndromes 
have been transformed into representations of In ~ vs. MLH, 
and are presented in Fig 11 and 12. 
It is obvious that t he patterns in these 2 figures are different 
from those for XP, even though the chemicals and radiations 
are for the most part the same. For AT data (Fig 11) the 
resistant tails, seen as dotted lines, indicate a proportion of the 
A T cells are r esistant to the various agents, and though a mixed 
population response (viz. , in tricate and difficult to in terpret), 
t here is li ttle doubt that the AT cells respond in a differen t way 
than do XP cells. It does appea r, however, that ext rapolation of 
th e response of the sensitive moeity of cells do es intercept ~ = 
1.0, MLH = 0, indicating differential re ponse of AT cells at 
lo w doses. This does not appear to be true with FA cells, since 
a threshold r esponse for In ~ is seen for all agents except MMC, 
X·RA Y 
UVC 
0.1 . 
0.01 
BUS 
PUVA 
MMC 
0 .001 L __ -L _ __ L __ -!-___ !-__ -+-__ -:;-__ ~ 
DO SE (MLH) 
FIG 12. Effects ratio as a function of MLH of normal human cells 
for fibroblasts from Fanconi's anemia patients treated with DNA-
damaging agents: MMC, mitomycin C, FA5, FA9, FA12, FA1 7, FA20 
a nd FA21 (ref. 2) ; BUS, busulfan, FA5 (ref. 2); PU\fA, psoralen plus 
ultraviolet A (365 nm) , FA5 (ref. 2); EMS, ethyl methane sulfonate, FA5 
(ref 2); U \fC, ultraviolet C (254 nm) FA5, FA9 and FAn (ref. 2); x ·ray, 
x-irradiation, FA5 (ref. 2). 
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where the steepness of the curve does not a llow interpretation 
of a possible shoulder. 
DISCUSSION 
R educing data as described in this paper offers a fa cile and 
useful method for the comparison of the magni tude and pattern 
of the induction of cytotoxicity by DNA dam aging agents. This 
comparison is useful in contrasting t he biological potency of 
different DNA-damaging chemical , a nd in contrasting the 
general characteristics of survival in cells fTom differen t human 
mutants. 
Generally, the response of norma l human cells to various 
DNA-damaging agents does not vary greatly: less than a factor 
of 6 when data are normalized to the maximum rate of cytotox-
icity. Epigenetic factors can extend the range of biological 
variation, but predominantly at doses which are much larger 
than expected in the natura l environment; doses which are, 
however, well in the range of the rapeutic regimens. 
The range of the cytotoxic response in cells from human 
mutants to DNA-damaging agents can be extremely wide . The 
degree and pattern of increased killing is dependent upon the 
particular muta nt cell , as well as the nature of the chall enging 
radia t ion or chemical. Thi wide range of variation was observed 
in XP, AT, a nd FA cells. The patterns of enhanced toxicity in 
XP, AT and FA cells were, however, quite different. A va riety 
of chemi cals produced enhanced killing in XP cells; consistent 
wi th the genetic defect acting as an effect-modifying-facto r, 
poten t iating the toxic effect of the chemical at all doses. In 
contrast, AT cells exhibited greater cytotoxicity at lower doses 
with a resistance observed at higher doses of all chemical 
exposure. The exception was expo ure to ionizing radiation 
where the enhanced toxicity was observed over all dose ranges. 
FA showed a pattern opposite to AT in t hat enhanced toxicity 
was greater at higher doses. Thus it seems inappropriate to 
consider these syndromes comparable in terms of probable 
molecular defects; for instance, to sea rch for deficiences in 
specific enzymes of DNA repa ir. Rather, more expe.rimental 
attention should be directed toward the processes whIch man-
ifest damage as biological detriment; in the case presented here, 
cytotox icity. 
A potential usefulness of the analyses presented is in the 
evaluation of new cytotoxic agents. The 8 of an agent as shown 
in Fig 10 appear s to be a useful, a nd perhaps, unique quanti ta -
tive predictor of some aspects of genetic tox icology . The com-
pariso n of such predictors in a battery of unique mu tant cell 
lines known to respond to certam mutage l1Ic! car cmogel1Ic 
agents may prove a useful tool in screening not only for potent ial 
therapeutic benefit, but a lso for possible hazard. 
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